Summary Macrophages can account for up to 50% of tumour mass and secrete many angiogenic factors. Furthermore, tumour hypoxia is thought to play a major role in the activation of macrophages and the regulation of angiogenesis. In this paper, we demonstrate a strong correlation between hypoxia and the recruitment of immune cells binding to IgG in 8 experimental tumours. We provide evidence that IgG binding immune cells in 3 tumour lines are predominately composed of macrophages. Reduced oxygenation may act as a stimulus for recruitment of immune cells to the tumour mass, and the detection of either IgG-positive host cells or macrophages may offer an alternative method for monitoring tumour hypoxia.
Solid tumours are not a mass of neoplastic cells in isolation; rather, they are a complex matrix of many cellular types that often outnumber the tumour cell population. Indeed, macrophages can account for up to 50% of the tumour mass in breast carcinoma (Kelly et al, 1988; O'Sullivan and Lewis, 1994; Leek et al, 1994) . Macrophages are known to be involved in the angiogenic process, and can be stimulated in hypoxic, avascular regions of the tumour microenvironment to secrete a wide range of angiogenic factors, including vascular endothelial growth factor (VEGF), basic fibroblast factor (bFGF), tumour necrosis factor α (TNFα), endothelial growth factor (EGF), interferons, and others (Leek et al, 1997) . Additionally, tumour hypoxia alone can also alter the effects of growth factors and cytokines, induce transcription factors and DNA repair enzymes, and has been associated with increased tumour aggressiveness (Brizel et al, 1996; Dachs and Stratford, 1996) . This led us to speculate that hypoxia may be acting as a stimulus for macrophage infiltration to help elicit the angiogenic response, and therefore the percentage of host cells within the tumour mass may correlate with, and provide a surrogate marker for, tumour hypoxia.
Tumour hypoxia is a major cause of radioresistance, and can also influence the efficacy of chemotherapy (Gray et al, 1953; Teicher et al, 1981) . Measurements of oxygen tension in human tumours using polarographic microelectrodes have demonstrated the existence of large hypoxic fractions (Höckel et al, 1993; Brizel et al, 1996; Nordsmark et al, 1996; Collingridge et al, 1999) , and other studies have shown that human tumour pO 2 can be modified to improve therapeutic response (Saunders and Dische, 1996; Hoskin et al, 1997) . The use of polarographic electrodes is restricted however by their invasive nature, and their limited accessibility to superficial tumours or sites exposed during surgery.
Deep-seated tumours of the bowel and digestive tract, for example, are not usually available for measurement. Non-invasive approaches utilizing MRI and PET are currently in development, and it is possible that surrogate markers that strongly correlate with tumour hypoxia may open other avenues of non-invasive pO 2 measurement. A routine method of assessing tumour oxygenation prior to, and during, therapy would allow monitoring of treatment efficacy, modification of treatment schedules as necessary, and individualization of therapy according to the patients' own physiology.
In this paper, we demonstrate that the infiltration of IgG-binding immune cells into solid experimental tumours strongly correlate with tumour hypoxia, and appear to be predominately derived from a macrophage lineage.
MATERIALS AND METHODS

Animals and tumour models
8 murine tumour models were used in this investigation. The anaplastic sarcoma F (SaF), and the adenocarcinomas NT (CaNT), X (CaX), and WW (CaWW) were transplanted subcutaneously into the rear dorsum of female CBA/Gy f TO mice. The methylcholanthrene-induced fibrosarcoma R (FsaR), the spontaneous fibrosarcoma N (FSaN), and the radiation-induced fibrosarcoma, RIF-1, were grown subcutaneously in the rear dorsum of female C3H/Gy f BXC/2 mice, and the adenocarcinoma RD (CaRD) was grown subcutaneously in the rear dorsum of female WHT/Gy f C57 B1 mice. SaF, CaNT, CaX, CaWW, and CaRD tumours arose spontaneously in the Gray Laboratory mouse colonies and were isolated and characterized between 1957 and 1980. FsaR and FsaN tumours were derived from the murine FSA fibrosarcoma (Milas et al, 1975 (Milas et al, , 1984 , and the RIF-1 tumour was originally characterized by Twentyman et al (1980) . All tumours, excluding RIF-1, were serially maintained by injecting 0.05 ml of a crude cell suspension prepared by mechanical dissociation of an excised
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tumour from a donor animal. RIF-1 tumours were inoculated by injecting 5 × 10 5 cells from exponentially growing cell cultures suspended in 0.05 ml of PBS. Tumours were selected for treatment when they had reached 5-8 mm in diameter (100-300 mg). All animal experiments were performed in full compliance with government regulations and UKCCCR guidelines on animal welfare.
Immune cell determination
2 fluorescein-labelled antibodies were used to assess the proportion of infiltrating immune cells in each tumour line by flow cytometry. Cell suspensions were labelled with a non-specific polyclonal antibody (goat anti-mouse IgG/FITC; Sigma-Aldrich Company Ltd, Dorset, UK), which binds to macrophages and other polymorphs, to determine a gross indication of the immune cell content. Cell suspensions from the SaF, CaNT, and FSaN tumours where also incubated with a monoclonal antibody (rat anti-mouse F4/80/FITC; Serotec Ltd, Kidlington, Oxford, UK) directed against the macrophage-specific F4/80 antigen (Hume and Gordon, 1983) . Tumour cell suspensions were obtained by excising solid tumours from host mice. A minimum of 3 tumours were assayed for each tumour line. The excised material was minced and enzymatically digested for 30 minutes at 37˚C with either Collagenase (type II; 2 mg ml -1 ; activity, >125 U mg -1 ), or Dispase (20 mg ml -1 ; activity, >6 U mg -1 ) dissolved in Hanks medium (Sigma-Aldrich Company Ltd, Dorset, UK). Both methods of digestion also contained DNase (type I; 0.2 mg ml -1 ; activity, 420 U mg -1 ). Following digestion, Hanks medium containing 7% fetal bovine serum was added to neutralize the enzymes and the samples were passed through a 25G needle and a 35 µm filter to obtain a single cell suspension. The suspensions were centrifuged and resuspended in cold PBS and placed on ice. All samples where kept ice-cold to inhibit polymorph activity and prevent phagocytosis of reagents.
To label the samples, cell suspensions were fixed with ice-cold 70% ethanol, and then washed and resuspended in PBS at a concentration of 7.5 × 10 5 cells ml -1 . To 2 ml aliquots, 20 µl of neat IgG/FITC or 80 µl of F4/80/FITC (diluted 1:4 in Trizma buffer) was added. Samples were then incubated on ice for 5 minutes (IgG/FITC) or 30 minutes (F4/80/FITC). Following incubation, samples were washed and resuspended in PBS and passed through a 25G needle. Finally, RNase (type I; 1 mg ml -1 ; activity, 50-100 U mg -1 ) and propidium iodide (1 mg ml -1 ) were added, and the samples analysed by flow cytometry (FACScan; Becton-Dickinson UK Ltd, Cowley, Oxford, UK) to determine the proportion of cells positively labelled with FITC.
Immune cell distributions were assessed for the SaF and FSaN tumours using Hoechst 33342 (4 mg ml -1 ; Sigma-Aldrich Company Ltd, Dorset, UK). This dye penetrates tumour tissue producing a gradient of fluorescence (visible in the u.v. range) that identifies the position of cells in situ relative to any functional vasculature (Chaplin et al, 1985) . Mice were given 0.1 ml intravenous injections of Hoechst 33342 20 minutes prior to tumour excision. Tumours were then labelled for immune cell content as described earlier. Using a Vantage Cell Sorter (Becton-Dickinson UK Ltd, Cowley, Oxford, UK) the distribution of Hoechst staining amongst the immune cells positively labelled for FITC was determined.
Measurement of oxygen tension
Oxygen measurements were performed using a pO 2 histograph (Eppendorf KIMOC 6650, Hamburg, Germany). Full operational details for this machine are described elsewhere (Collingridge et al, 1997) . Briefly, un-anaesthetized tumour-bearing mice were restrained in Perspex jigs exposing the rear dorsum. A reference Ag/AgCl electrode (Medicotest UK Ltd, St Ives, Cambridgeshire, UK) was attached to a shaved region on the back of each animal, and the jig was placed on a thermal barrier (Vetko, CO, USA) to maintain core temperature. Using a net step length of 0.6 mm, 40-70 pO 2 measurements were made from 6 tracks through each tumour. 5-35 tumours were measured for each experimental model. All oxygen measurements were post-calibrated to account for barometric pressure and tumour temperature. The median pO 2 and the percentage of pO 2 readings <2.5 mmHg was calculated for each tumour and then averaged for each experimental model. Figure 1 shows the results from a representative sarcoma F tumour labelled with both FITC conjugated IgG ( Figure 1A Figure 2 shows the distribution of Hoechst 33342 labelling of the SaF. Tumour cells, with a low affinity for IgG (Figure 2A) , showed a Hoechst 33342 labelling profile ( Figure 2C ), which indicated a large number of cells with a strong incorporation of the dye, whilst progressively fewer proportions of cells with lesser degrees of incorporation, in other words, the data shows a gradient of staining extending from functional vasculature into less vascular regions. Additionally, the Hoechst 33342 profile ( Figure 2D ) for the IgG labelled immune cells ( Figure 2B ) was near identical to the tumour cell labelling, thus indicating the presence of immune cells distant from the Measurements of oxygen tension within the 8 types of tumour varied significantly. The median pO 2 s ranged from 0.4 mmHg for the FSaN to 3.1 mmHg for the CaX, whilst the percentage of pO 2 readings less than 2.5 mmHg ranged from 46.3% to 89.4%. Figure 3 correlates the oxygen tensions of the solid tumours with their corresponding IgG-positive immune cell contents. There is a strong correlation between the 2 parameters indicating that with decreasing oxygenation, or conversely, increasing hypoxic fraction, the proportion of immune cells binding to IgG within the tumour mass increased.
RESULTS
DISCUSSION
Macrophages represent a major component of the lymphoreticular infiltrate in tumours. In this paper, we demonstrate that up to 50% of the total tumour volume can be attributable to IgG-binding immune cells, which appear to be comprised predominately of macrophages. Other investigators have also reported large proportions of tumour-associated macrophages. Milas and colleagues (1987) have shown the macrophage content in a variety of murine tumours can vary from 9 to 83%, whilst Olive (1989) identified a macrophage content of between 20-60% in the murine SCCVII carcinoma. Similarly, tumour-associated macrophage content in human tumours can also be high. In a study of 20 human tumour biopsies of differing histology, Svennevig et al detected up to 28% of the biopsied tissue contained macrophages (1979) . More recently, high proportions of macrophages have been measured in human breast carcinoma (Leek et al, 1997 (Leek et al, , 1999 .
The data presented here does not allow us to comment on the absolute distribution of macrophages in the tumour mass. Hoechst 33342 stains cells relative to their distance from functional vasculature in accordance with the diffusion properties of the dye. The distribution profile shown in Figure 2D indicates that some cells were labelled weakly, and therefore they must have been at the limits of the diffusible range for Hoechst 33342. One can conclude that these cells must have migrated from the blood vessels into the The role of macrophage recruitment to neoplastic tissue is complex, since macrophages have numerous functions related to tissue remodelling, inflammation, immunity and thrombosis. Thus they have the capacity to affect tumour vascularization, growth rate, stroma formation, and apoptotic cell death (Mantovani et al, 1992) . Leek et al (1997) have shown that higher numbers of macrophages are found in angiogenic breast tumours and that they are concentrated in avascular, hypoxic regions of the tumour, consistent with many other reports indicating high macrophage numbers in avascular necrotic sites . Hypoxia is known to stimulate the angiogenic activity of macrophages, and macrophage-derived VEGF is upregulated under low oxygen tensions (Harmey et al, 1998) . Furthermore, the macrophagederived peptide, PR39, can prevent degradation of hypoxiainducible-factor 1α (HIF-1) and, because HIF-1 is an upstream regulator of VEGF, this can promote angiogenesis (Li et al, 1999; Ozaki et al, 2000) .
It has been suggested, that macrophages are attracted to the tumour matrix by following a falling oxygen gradient or by chemoattractants released from stressed or necrotic cells (Leek et al, 1997) . Consistent with these theories, breast cancer patients with low macrophage indices have a lower risk of recurrence and increased overall survival rates (Leek et al, 1997) , furthermore, experimental studies have shown a trend between high macrophage numbers and radioresistance (Milas et al, 1987) . These studies suggest that radiobiologically hypoxic tumours are targets for angiogenic activity, presumably to improve nutrient supply and drainage, and unsurprisingly have poor response rates to therapy. The results presented in this paper are in agreement with these conclusions. We show, amongst a range of experimental tumours, that those tumours exhibiting the highest levels of hypoxia also contain the highest proportions of IgG-binding immune cells. Furthermore, additional experimental data, that is not presented in this paper, provides us with little evidence to suggest that these cells are attracted to tumours containing high necrotic fractions to facilitate dead cell clearance; this leads us to conclude therefore, that hypoxia plays a key role in IgG-positive immune cell migration. It is important to highlight that the tumour models used in this study exhibit a range of oxygen tensions at the lower end of the spectrum, and further work is now needed to evaluate the immune cell content in well oxygenated tumours to examine the full dynamic range of the relationship. Furthermore, it would be useful to determine the strength of the relationship between tumours of the same type, and thereby examine a more clinically relevant endpoint, namely, whether one patient could be distinguished from another, rather than groups of patients from each other.
A strong correlation between IgG-positive immune cell content and tumour hypoxia may potentially offer an alternative method of measuring oxygenation. Non-invasive methods of detecting tumour hypoxia using MRI, EPR and PET are currently in development (Aboagye et al, 1998; O'Hara et al, 1998; Evans et al, 2000) . PK11195, for example, binds to activated macrophages (Zovala and Lenfant, 1987) , and PET studies using 11 C-PK11195 at Hammersmith hospital are being conducted to image macrophage infiltration during neuro-inflammation in Rasmussen's encephalitis (Banati et al, 1999 ); thus it may be possible to utilize this imaging approach to indirectly measure tumour hypoxia in addition to macrophage activation states. Furthermore, macrophage measurement may evade the potential risks associated with many conventional nitroimidazole-based hypoxic markers, which can have mutagenic and carcinogenic effects (Voogd, 1981; Tocher, 1997) .
In conclusion, this paper shows that the proportion of IgGbinding immune cells in solid tumours correlates with the degree of hypoxia, and that decreased oxygen gradients may act as a stimulus for cell recruitment to neoplastic tissue. Furthermore, a majority of the IgG-positive cells appear to be of a macrophage lineage, and thus the detection of macrophages may provide an indirect method of determining the hypoxic fraction in human tumours. 
